Current Research Studies - Heart & Vascular

The following list contains clinical studies in which the OSF HealthCare Cardiovascular Institute is enrolling patients.

For questions or to enroll, please contact our research staff at (309) 589-1930 in the Peoria area and (815) 395-9181 in Rockford.

Peoria Area

  • PRESERVED HF - Effects of dapagliflozin on biomarkers, symptoms and functional status in patients with Type 2 diabetes or pre-diabetes, and PRESERVED ejection fraction Heart Failure

  • Summary: A study to evaluate the effects of Dapagliflozin on biomarkers, symptoms and functional status in patients with Type II Diabetes or pre-diabetes, and preserved Ejection Fraction Heart Failure.

    Investigator: Barry Clemson

    Location: OSF HealthCare Cardiovascular Institute, Peoria, Illinois

    ClinicalTrials.gov: NCT03030235

    Contact: Stephanie Hillis, (309) 589-1934, stephanie.j.hillis@osfhealthcare.org